Physician profile
John M Pierce
NPI 1417099359
$3,424.35
in general payments reported to CMS, 2019-2025
13 companies · $6.45 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $630 · 2020: $96.76 · 2021: $1,184 · 2022: $579 · 2023: $104 · 2024: $824 · 2025: $6.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $824 · Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $823.94 |
| Food and Beverage | $110.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,394.30 | 2020-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Intuitive Surgical, INC. | $823.94 | 2024 | |
| Mentor Worldwide LLC | $588.19 | 2019-2021 | |
| Allergan, INC. | $211.18 | 2019-2022 | |
| Polarityte, INC. | $98.36 | 2019 | |
| Galderma Laboratories, L.P. | $95.00 | 2021 | |
| Kci USA, INC. | $85.27 | 2019 | |
| Davol INC. | $38.49 | 2021 | |
| Integra Lifesciences Corporation | $28.15 | 2019-2020 | |
| Ethicon US, LLC | $21.09 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.44 | 2023 | Seglentis |
| Innocoll Pharmaceuticals Limited | $14.49 | 2021 | |
| Reflow Medical INC | $6.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.